Clinical Trial

EDP167 in Healthy Volunteers and Subjects With Mild Dyslipidemia

Name: EDP167 in Healthy Volunteers and Subjects With Mild Dyslipidemia — clinical trial record (NCT07412080)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

EDP167 is a double-stranded small interfering RNA (siRNA) drug targeting ANGPTL3, which may bring benefits for patients with dyslipidemia conditions. This is the first in human study of EDP167 in health volunteers and subjects with mild dyslipidemia to evaluate the safety and PK/PD profiles of EDP167.

Trial Details

NCT Number	NCT07412080
Lead Sponsor	Eddingpharm (Zhuhai) Co., Ltd.
Conditions	Healthy Adult Male and Female Volunteers, Mild Dyslipidemia
Enrollment	40 participants
Start Date	2025-07-01
Primary Completion	2025-12-12 (estimated)
Study Completion	2025-12-12 (estimated)
Updated on ClinicalTrials.gov	2026-02-17